美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

吉利德科學

139.03

+0.04000.03%

盤後：139.160.1300+0.09%18:10 EDT

成交量：510.15萬

成交額：7.07億

市值：1,724.92億

市盈率：20.51

高：139.55

開：137.99

低：137.02

收：138.99

52周最高：157.29

52周最低：93.37

股本：12.41億

流通股本：12.38億

量比：1.11

換手率：0.41%

股息：3.16

股息率：2.27%

每股收益(TTM):6.78

每股收益(LYR):6.78

淨資產收益率：40.66%

總資產收益率：12.52%

市淨率：7.60

市盈率(LYR):20.51

資料載入中...

總覽公司新聞資訊公告

吉利德科學正與Galapagos就收購的Ouro Medicines資產展開研發合作深入談判

吉利德科學將收購Ouro Medicines，推進其首創的T細胞銜接器項目以治療自身免疫性疾病

據英國《金融時報》報導，吉利德接近以最高20億美元收購生物技術公司Ouro Medicines

吉利德科學與Ouro Medicines談判進入後期階段交易有望近日公布

吉利德科學將以約15億美元現金預付款收購Ouro，若臨床試驗達標還將額外支付至少5億美元

BUZZ-Xilio股價因意外季度盈利而上漲

吉利德科學(GILD.US)CD19/CD20 CAR-T細胞療法啓動III期臨床

吉利德科學(GILD)股票3月18日盤中下跌3.37%：投資者必看的核心信息

TradingKey中文

埃斯瓦提尼開始使用來那卡韋遏制艾滋病毒傳播

華爾街機構的錢都去哪了？美銀最新報告：全在AI裏，Palantir(PLTR.US)、博通(AVGO.US)排隊吸金

吉利德科學盤中異動早盤股價大跌3.00%報143.78美元

南非尋求在當地生產吉利德公司的艾滋病預防藥物

吉利德高管稱Anito-Cel有望覆蓋「高達200億美元」多發性骨髓瘤市場機遇，考慮一線治療應用——TD Cowen會議

吉利德基金會斥資1200萬美元賦能社區衞生工作者，在14個州及哥倫比亞特區擴大艾滋病預防計劃

在晚期研究中，United Therapeutics 的藥物減緩了罕見肺病的惡化速度

吉利德科學股票2月27日盤中上漲3.72%：真相來了

TradingKey中文

吉利德公司的試驗性艾滋病治療藥物在研究中顯示出較低的停藥率

BUZZ-券商觀點：吉利德收購 Arcellx 是對癌症細胞療法的長期押注

78億美金，跨國藥企達成閃電併購

药圈观察局

特定條件下交易終止 Arcellx將向吉利德科學支付2.6億美元解約金

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/GILD/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GILD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GILD\",,,,,undefined,":{"symbol":"GILD","market":"US","secType":"STK","nameCN":"吉利德科學","latestPrice":139.03,"timestamp":1776110400000,"preClose":138.99,"halted":0,"volume":5101463,"hourTrading":{"tag":"盘后","latestPrice":139.16,"preClose":139.03,"latestTime":"18:10 EDT","volume":860438,"amount":119626127.25092,"timestamp":1776118257369,"change":0.13,"changeRate":0.000935,"amplitude":0.013235},"delay":0,"changeRate":0.000287790488524297,"floatShares":1238162880,"shares":1240679623,"eps":6.78,"marketStatus":"盤後交易","change":0.04,"latestTime":"04-13 18:15:22 EDT","open":137.99,"high":139.55,"low":137.02,"amount":706865141.1233801,"amplitude":0.018203,"askPrice":141.5,"askSize":1,"bidPrice":139.03,"bidSize":8,"shortable":3,"etf":0,"ttmEps":6.78,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1776124800000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":696056400000,"exchange":"NASDAQ","adjPreClose":138.99,"dividendRate":0.022729,"preHourTrading":{"tag":"盘前","latestPrice":138.31,"preClose":138.99,"latestTime":"09:29 EDT","volume":2074,"amount":286551.47232,"timestamp":1776086999999,"change":-0.68,"changeRate":-0.004892,"amplitude":0.023516},"postHourTrading":{"tag":"盘后","latestPrice":139.16,"preClose":139.03,"latestTime":"18:10 EDT","volume":860438,"amount":119626127.25092,"timestamp":1776118257369,"change":0.13,"changeRate":0.000935,"amplitude":0.013235},"volumeRatio":1.113104,"optionData":{"bulkOrders":[{"symbol":"GILD","call":false,"expireDate":1778817600000,"strike":"130.0","timestamp":1776097517058,"price":2.66,"volume":3000,"amount":798000,"type":"+"}]},"impliedVol":0.3545,"impliedVolPercentile":0.688},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GILD\",,,,,undefined,":{"symbol":"GILD","floatShares":1238162880,"roa":"12.52%","roe":"40.66%","lyrEps":6.78,"volumeRatio":1.113104,"shares":1240679623,"dividePrice":3.16,"high":139.55,"amplitude":0.018203,"preClose":138.99,"low":137.02,"week52Low":93.37,"pbRate":"7.60","psRate":"5.86","week52High":157.29,"institutionHeld":0.8716,"latestPrice":139.03,"committee":0.777778,"eps":6.78,"divideRate":0.022729,"volume":5101463,"delay":0,"ttmEps":6.78,"open":137.99,"prevYearClose":122.74,"prevWeekClose":138.99,"prevMonthClose":139.37,"prevQuarterClose":139.37,"fiveDayClose":140.13,"twentyDayClose":144.99,"sixtyDayClose":124.07,"dividendPayoutRate":0.46193184575686363,"dividendFrequency":"Q","dividendGrowthYears":10,"dividendGrowthRate":0.025974025974025997,"fiveYearAvgDividendRate":0.03377732217604273},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GILD\",params:#limit:5,,,undefined,":[{"date":"2026-03-13","symbol":"GILD","amount":0.82,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-13","defaultRemindTime":1773408600000,"name":"吉利德科学","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-30","payableDate":"2026-03-13","currency":"USD","dateTimestamp":1773374400000,"payDate":"2026-03-30"},{"market":"US","date":"2026-02-10","symbol":"GILD","fiscalQuarterEnding":"2025/12","expectedEps":1.83,"name":null,"time":"盤後","type":"earning","dateTimestamp":1770699600000,"reportTimeType":"post","actualEps":1.9},{"date":"2025-12-15","symbol":"GILD","amount":0.79,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-15","defaultRemindTime":1765809000000,"name":"吉利德科学","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-30","payableDate":"2025-12-15","currency":"USD","dateTimestamp":1765774800000,"payDate":"2025-12-30"},{"market":"US","date":"2025-10-30","symbol":"GILD","fiscalQuarterEnding":"2025/09","expectedEps":2.15,"name":null,"time":"盤後","type":"earning","dateTimestamp":1761796800000,"reportTimeType":"post","actualEps":2.47},{"date":"2025-09-15","symbol":"GILD","amount":0.79,"announcedDate":"2025-08-07","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-15","defaultRemindTime":1757943000000,"name":"吉利德科学","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-29","payableDate":"2025-09-15","currency":"USD","dateTimestamp":1757908800000,"payDate":"2025-09-29"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GILD\",market:\"US\",,,undefined,":[{"executeDate":"2016-06-14","recordDate":"2016-06-16","paymentDate":"2016-06-29","value":0.47,"currency":"USD"},{"executeDate":"2016-09-14","recordDate":"2016-09-16","paymentDate":"2016-09-29","value":0.47,"currency":"USD"},{"executeDate":"2016-12-13","recordDate":"2016-12-15","paymentDate":"2016-12-29","value":0.47,"currency":"USD"},{"executeDate":"2017-03-14","recordDate":"2017-03-16","paymentDate":"2017-03-30","value":0.52,"currency":"USD"},{"executeDate":"2017-06-14","recordDate":"2017-06-16","paymentDate":"2017-06-29","value":0.52,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GILD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2727,"buy":0.5152,"hold":0.2121,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5152,"analysts":33,"updateTime":1773201600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GILD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GILD","date":"2026-04-10","current":20.326696,"percent":0.512255,"low":11.012226,"twenty":16.795866,"median":20.244608,"eighty":117.698348,"high":985.638037,"avg":108.084562,"sd":216.036166,"marketCap":176365235827},"quantilePoints":[{"date":"2021-04-16","current":684.496566,"twenty":5.886815,"median":14.653082,"eighty":31.596225,"marketCap":84193077595},{"date":"2021-04-23","current":670.268209,"twenty":5.886815,"median":14.712213,"eighty":42.207393,"marketCap":82442989695},{"date":"2021-04-30","current":265.489326,"twenty":5.886815,"median":14.778694,"eighty":42.567879,"marketCap":79912287049},{"date":"2021-05-07","current":277.252542,"twenty":5.886815,"median":14.856386,"eighty":42.894314,"marketCap":83453015165},{"date":"2021-05-14","current":285.544285,"twenty":5.886815,"median":14.904321,"eighty":43.205482,"marketCap":85948829715},{"date":"2021-05-21","current":286.46096,"twenty":5.886815,"median":15.044244,"eighty":43.463811,"marketCap":86224748912},{"date":"2021-05-28","current":275.460859,"twenty":5.886815,"median":15.158818,"eighty":43.913538,"marketCap":82913718554},{"date":"2021-06-04","current":280.960909,"twenty":5.886815,"median":15.193582,"eighty":44.006301,"marketCap":84569233733},{"date":"2021-06-11","current":286.544294,"twenty":5.886815,"median":15.256684,"eighty":44.397317,"marketCap":86249832475},{"date":"2021-06-18","current":277.544211,"twenty":5.886815,"median":15.331847,"eighty":44.793017,"marketCap":83540807637},{"date":"2021-06-25","current":282.835927,"twenty":5.886815,"median":15.396911,"eighty":44.953898,"marketCap":85133613908},{"date":"2021-07-02","current":288.752648,"twenty":5.886815,"median":15.472548,"eighty":45.316733,"marketCap":86914546903},{"date":"2021-07-09","current":284.252606,"twenty":5.886815,"median":15.579206,"eighty":45.697022,"marketCap":85560034484},{"date":"2021-07-16","current":285.960955,"twenty":5.886815,"median":15.726234,"eighty":45.841484,"marketCap":86074247532},{"date":"2021-07-23","current":287.58597,"twenty":5.886815,"median":15.752152,"eighty":47.568365,"marketCap":86563377017},{"date":"2021-07-30","current":16.591985,"twenty":5.886815,"median":15.856378,"eighty":51.009533,"marketCap":85647826956},{"date":"2021-08-06","current":16.706124,"twenty":5.886815,"median":15.9165,"eighty":51.009533,"marketCap":86237013283},{"date":"2021-08-13","current":17.284208,"twenty":5.886815,"median":16.177233,"eighty":51.009533,"marketCap":89221079750},{"date":"2021-08-20","current":17.59511,"twenty":5.886815,"median":16.446515,"eighty":51.009533,"marketCap":90825955833},{"date":"2021-08-27","current":17.313355,"twenty":5.886815,"median":16.628399,"eighty":51.009533,"marketCap":89371536883},{"date":"2021-09-03","current":17.478521,"twenty":5.886815,"median":16.94972,"eighty":51.009533,"marketCap":90224127302},{"date":"2021-09-10","current":17.242916,"twenty":5.886815,"median":16.972053,"eighty":51.009533,"marketCap":89007932145},{"date":"2021-09-17","current":17.393509,"twenty":5.886815,"median":17.123861,"eighty":51.009533,"marketCap":89785293998},{"date":"2021-09-24","current":17.291494,"twenty":5.886815,"median":17.235629,"eighty":51.009533,"marketCap":89258694033},{"date":"2021-10-01","current":16.652688,"twenty":5.886815,"median":17.235629,"eighty":51.009533,"marketCap":85961175206},{"date":"2021-10-08","current":16.528813,"twenty":5.886815,"median":17.235629,"eighty":51.009533,"marketCap":85321732392},{"date":"2021-10-15","current":16.426798,"twenty":5.886815,"median":17.235629,"eighty":51.009533,"marketCap":84795132427},{"date":"2021-10-22","current":16.33207,"twenty":5.886815,"median":17.235629,"eighty":51.009533,"marketCap":84306146745},{"date":"2021-10-29","current":11.012226,"twenty":5.886815,"median":17.235629,"eighty":51.009533,"marketCap":81424400000},{"date":"2021-11-05","current":11.251111,"twenty":5.886815,"median":17.235629,"eighty":51.009533,"marketCap":83190715179},{"date":"2021-11-12","current":11.447904,"twenty":5.893685,"median":17.235629,"eighty":51.009533,"marketCap":84645800064},{"date":"2021-11-19","current":11.653179,"twenty":5.897479,"median":17.235629,"eighty":51.009533,"marketCap":86163604126},{"date":"2021-11-26","current":11.921224,"twenty":5.918211,"median":17.235629,"eighty":51.009533,"marketCap":88145530090},{"date":"2021-12-03","current":11.800773,"twenty":6.026147,"median":17.235629,"eighty":51.009533,"marketCap":87254917790},{"date":"2021-12-10","current":11.917831,"twenty":6.210409,"median":17.235629,"eighty":51.009533,"marketCap":88120442420},{"date":"2021-12-17","current":12.250343,"twenty":6.275567,"median":17.235629,"eighty":51.009533,"marketCap":90579034123},{"date":"2021-12-23","current":12.296148,"twenty":6.286831,"median":17.235629,"eighty":51.009533,"marketCap":90917717674},{"date":"2021-12-31","current":12.318202,"twenty":6.311092,"median":17.235629,"eighty":51.009533,"marketCap":91080787532},{"date":"2022-01-07","current":12.089176,"twenty":6.331714,"median":17.2332,"eighty":50.998121,"marketCap":89387369777},{"date":"2022-01-14","current":12.175697,"twenty":6.376154,"median":17.2332,"eighty":50.998121,"marketCap":90027105373},{"date":"2022-01-21","current":11.622642,"twenty":6.392142,"median":17.2332,"eighty":50.998121,"marketCap":85937815092},{"date":"2022-01-28","current":11.682019,"twenty":6.427197,"median":17.2332,"eighty":50.998121,"marketCap":86376849324},{"date":"2022-02-04","current":12.876322,"twenty":6.478068,"median":17.2332,"eighty":50.998121,"marketCap":80155107055},{"date":"2022-02-11","current":12.507564,"twenty":6.506803,"median":17.2332,"eighty":50.998121,"marketCap":77859585210},{"date":"2022-02-18","current":12.302026,"twenty":6.55983,"median":17.2332,"eighty":50.998121,"marketCap":76580114018},{"date":"2022-02-25","current":12.311254,"twenty":6.578904,"median":17.2332,"eighty":50.998121,"marketCap":76637556570},{"date":"2022-03-04","current":12.46031,"twenty":6.599937,"median":17.2332,"eighty":50.998121,"marketCap":77565432746},{"date":"2022-03-11","current":11.6828,"twenty":6.635114,"median":17.2332,"eighty":50.998121,"marketCap":72725429992},{"date":"2022-03-18","current":11.968827,"twenty":6.678391,"median":17.2332,"eighty":50.998121,"marketCap":74505949140},{"date":"2022-03-25","current":11.884082,"twenty":6.698205,"median":17.2332,"eighty":50.998121,"marketCap":73978409872},{"date":"2022-04-01","current":12.037399,"twenty":8.02258,"median":17.2332,"eighty":50.998121,"marketCap":74932807962},{"date":"2022-04-08","current":12.567956,"twenty":8.716567,"median":17.2332,"eighty":50.998121,"marketCap":78235527670},{"date":"2022-04-14","current":12.471124,"twenty":8.90123,"median":17.2332,"eighty":50.998121,"marketCap":77632749929},{"date":"2022-04-22","current":12.55787,"twenty":9.141519,"median":17.2332,"eighty":50.998121,"marketCap":78172738322},{"date":"2022-04-29","current":16.504629,"twenty":9.361538,"median":17.2332,"eighty":50.998121,"marketCap":74518398265},{"date":"2022-05-06","current":16.996433,"twenty":10.809551,"median":17.239272,"eighty":50.998121,"marketCap":76738896748},{"date":"2022-05-13","current":17.327028,"twenty":11.245343,"median":17.247681,"eighty":50.998121,"marketCap":78231529751},{"date":"2022-05-20","current":17.735409,"twenty":11.419063,"median":17.289789,"eighty":50.998121,"marketCap":80075370520},{"date":"2022-05-27","current":18.002107,"twenty":11.443493,"median":17.319427,"eighty":50.998121,"marketCap":81279511430},{"date":"2022-06-03","current":17.627063,"twenty":11.598891,"median":17.34736,"eighty":50.998121,"marketCap":79586188275},{"date":"2022-06-10","current":16.874197,"twenty":11.674743,"median":17.353688,"eighty":50.998121,"marketCap":76186998831},{"date":"2022-06-17","current":16.260236,"twenty":11.693895,"median":17.353688,"eighty":50.998121,"marketCap":73414966111},{"date":"2022-06-24","current":17.524273,"twenty":11.796701,"median":17.385368,"eighty":51.009533,"marketCap":79122092299},{"date":"2022-07-01","current":17.32425,"twenty":11.863803,"median":17.393509,"eighty":51.009533,"marketCap":78218986617},{"date":"2022-07-08","current":17.457598,"twenty":11.905616,"median":17.41294,"eighty":51.009533,"marketCap":78821057072},{"date":"2022-07-15","current":17.390924,"twenty":11.935322,"median":17.41294,"eighty":51.009533,"marketCap":78520021844},{"date":"2022-07-22","current":16.890865,"twenty":11.980941,"median":17.41294,"eighty":51.009533,"marketCap":76262257638},{"date":"2022-07-29","current":16.599165,"twenty":12.028097,"median":17.41294,"eighty":51.009533,"marketCap":74945228518},{"date":"2022-08-05","current":18.52212,"twenty":12.086156,"median":17.427039,"eighty":51.009533,"marketCap":76626008538},{"date":"2022-08-12","current":19.074694,"twenty":12.171909,"median":17.456661,"eighty":51.009533,"marketCap":78912011126},{"date":"2022-08-19","current":19.795752,"twenty":12.222347,"median":17.478521,"eighty":51.009533,"marketCap":81895025523},{"date":"2022-08-26","current":18.895945,"twenty":12.254415,"median":17.529437,"eighty":51.009533,"marketCap":78172524363},{"date":"2022-09-02","current":19.335245,"twenty":12.287819,"median":17.577057,"eighty":51.009533,"marketCap":79989907085},{"date":"2022-09-09","current":19.777574,"twenty":12.303022,"median":17.627063,"eighty":51.009533,"marketCap":81819823480},{"date":"2022-09-16","current":19.874523,"twenty":12.328536,"median":17.735409,"eighty":51.009533,"marketCap":82220901046},{"date":"2022-09-23","current":19.044398,"twenty":12.37249,"median":17.877092,"eighty":51.009533,"marketCap":78786674386},{"date":"2022-09-30","current":18.689929,"twenty":12.440381,"median":18.002107,"eighty":51.009533,"marketCap":77320234535},{"date":"2022-10-07","current":19.477638,"twenty":12.472434,"median":18.174606,"eighty":51.009533,"marketCap":80578989760},{"date":"2022-10-14","current":20.047213,"twenty":12.542538,"median":18.389663,"eighty":51.009533,"marketCap":82935320460},{"date":"2022-10-21","current":20.538017,"twenty":12.806741,"median":18.504662,"eighty":51.009533,"marketCap":84965775639},{"date":"2022-10-28","current":29.80037,"twenty":13.013399,"median":18.615892,"eighty":51.009533,"marketCap":99354433322},{"date":"2022-11-04","current":30.22374,"twenty":13.251735,"median":18.662662,"eighty":51.009533,"marketCap":100765950507},{"date":"2022-11-11","current":30.780513,"twenty":13.37445,"median":18.717011,"eighty":51.009533,"marketCap":102622231397},{"date":"2022-11-18","current":31.45767,"twenty":13.431735,"median":18.843409,"eighty":51.009533,"marketCap":104879870318},{"date":"2022-11-25","current":32.450832,"twenty":13.459519,"median":18.879888,"eighty":51.009533,"marketCap":108191074069},{"date":"2022-12-02","current":33.4929,"twenty":13.504605,"median":18.899024,"eighty":51.009533,"marketCap":111665329520},{"date":"2022-12-09","current":33.09413,"twenty":13.606687,"median":18.972334,"eighty":51.009533,"marketCap":110335831044},{"date":"2022-12-16","current":32.638931,"twenty":13.64752,"median":19.040589,"eighty":51.009533,"marketCap":108818195992},{"date":"2022-12-23","current":31.882773,"twenty":13.702003,"median":19.108021,"eighty":51.009533,"marketCap":106297165863},{"date":"2022-12-30","current":32.296591,"twenty":13.772637,"median":19.194795,"eighty":51.009533,"marketCap":107676834093},{"date":"2023-01-06","current":33.135512,"twenty":13.805022,"median":19.238296,"eighty":51.009533,"marketCap":110473797867},{"date":"2023-01-13","current":32.454594,"twenty":13.873802,"median":19.29283,"eighty":51.009533,"marketCap":108203616508},{"date":"2023-01-20","current":31.228189,"twenty":13.90331,"median":19.320096,"eighty":51.009533,"marketCap":104114781573},{"date":"2023-01-27","current":31.499051,"twenty":13.995449,"median":19.384392,"eighty":51.009533,"marketCap":105017837141},{"date":"2023-02-03","current":22.946755,"twenty":14.041486,"median":19.450119,"eighty":51.009533,"marketCap":105371500000},{"date":"2023-02-10","current":23.544186,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":108114900000},{"date":"2023-02-17","current":23.017361,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":105695720000},{"date":"2023-02-24","current":21.905815,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":100591501721},{"date":"2023-03-03","current":22.017164,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":101102814834},{"date":"2023-03-10","current":21.59078,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":99144859743},{"date":"2023-03-17","current":20.996015,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":96413699455},{"date":"2023-03-24","current":21.756377,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":99905284240},{"date":"2023-03-31","current":22.564083,"twenty":14.066937,"median":19.46767,"eighty":50.998121,"marketCap":103614267917},{"date":"2023-04-06","current":22.749012,"twenty":14.066937,"median":19.46767,"eighty":50.998121,"marketCap":104463462833},{"date":"2023-04-14","current":22.645669,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":103988912733},{"date":"2023-04-21","current":23.031845,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":105762231528},{"date":"2023-04-28","current":18.688623,"twenty":14.055938,"median":19.442338,"eighty":51.020944,"marketCap":104338581228},{"date":"2023-05-05","current":17.542922,"twenty":14.055938,"median":19.3806,"eighty":51.020944,"marketCap":97942133140},{"date":"2023-05-12","current":17.583137,"twenty":14.055938,"median":19.319381,"eighty":51.020944,"marketCap":98166656624},{"date":"2023-05-19","current":17.473662,"twenty":14.050438,"median":19.278218,"eighty":51.032356,"marketCap":97555453806},{"date":"2023-05-26","current":17.348547,"twenty":14.044939,"median":19.233751,"eighty":51.043768,"marketCap":96856936300},{"date":"2023-06-02","current":17.026822,"twenty":14.044939,"median":19.162011,"eighty":51.043768,"marketCap":95060748428},{"date":"2023-06-08","current":16.997778,"twenty":14.044939,"median":19.104641,"eighty":51.043768,"marketCap":94898592579},{"date":"2023-06-16","current":17.650163,"twenty":14.039759,"median":19.040589,"eighty":51.200274,"marketCap":98540862431},{"date":"2023-06-23","current":17.45132,"twenty":14.038033,"median":18.973525,"eighty":51.252442,"marketCap":97430718537},{"date":"2023-06-30","current":16.982138,"twenty":14.036306,"median":18.920182,"eighty":51.304611,"marketCap":94811277890},{"date":"2023-07-07","current":17.033525,"twenty":14.036306,"median":18.886384,"eighty":51.304611,"marketCap":95098169009},{"date":"2023-07-14","current":17.138532,"twenty":14.036306,"median":18.848464,"eighty":51.304611,"marketCap":95684424773},{"date":"2023-07-21","current":17.860178,"twenty":14.036306,"median":18.770739,"eighty":51.304611,"marketCap":99713373958},{"date":"2023-07-28","current":17.093848,"twenty":14.036306,"median":18.679091,"eighty":51.304611,"marketCap":95434954235},{"date":"2023-08-04","current":17.179531,"twenty":14.036306,"median":18.633127,"eighty":51.304611,"marketCap":94212548600},{"date":"2023-08-11","current":18.176723,"twenty":14.036306,"median":18.52212,"eighty":51.304611,"marketCap":99681148240},{"date":"2023-08-18","current":17.381491,"twenty":14.036306,"median":18.429012,"eighty":51.304611,"marketCap":95320098004},{"date":"2023-08-25","current":17.342866,"twenty":14.036306,"median":18.328953,"eighty":51.304611,"marketCap":95108275564},{"date":"2023-09-01","current":17.376947,"twenty":14.036306,"median":18.1949,"eighty":51.304611,"marketCap":95295177717},{"date":"2023-09-08","current":16.799836,"twenty":14.036306,"median":18.174606,"eighty":51.304611,"marketCap":92130301260},{"date":"2023-09-15","current":17.576891,"twenty":14.036306,"median":18.052169,"eighty":51.304611,"marketCap":96391670348},{"date":"2023-09-22","current":17.102024,"twenty":14.036306,"median":17.993772,"eighty":51.304611,"marketCap":93787500350},{"date":"2023-09-29","current":17.136105,"twenty":14.036306,"median":17.876807,"eighty":51.304611,"marketCap":93974402503},{"date":"2023-10-06","current":16.972515,"twenty":14.036306,"median":17.771527,"eighty":51.304611,"marketCap":93077272169},{"date":"2023-10-13","current":17.440566,"twenty":14.036306,"median":17.722305,"eighty":51.304611,"marketCap":95644061736},{"date":"2023-10-19","current":18.101744,"twenty":14.036306,"median":17.689975,"eighty":51.304611,"marketCap":99269963503},{"date":"2023-10-27","current":17.835909,"twenty":14.029482,"median":17.676863,"eighty":51.032356,"marketCap":97812126710},{"date":"2023-11-03","current":18.45619,"twenty":14.029482,"median":17.650163,"eighty":33.471833,"marketCap":101213745894},{"date":"2023-11-10","current":15.89997,"twenty":14.029482,"median":17.641227,"eighty":33.09714,"marketCap":93428221287},{"date":"2023-11-17","current":15.802424,"twenty":14.029482,"median":17.615533,"eighty":32.981271,"marketCap":92855042015},{"date":"2023-11-24","current":15.984792,"twenty":14.029482,"median":17.59511,"eighty":32.559177,"marketCap":93926638045},{"date":"2023-12-01","current":16.243501,"twenty":14.029482,"median":17.57082,"eighty":32.289819,"marketCap":95446809157},{"date":"2023-12-08","current":16.550982,"twenty":14.031188,"median":17.55419,"eighty":32.133321,"marketCap":97253569904},{"date":"2023-12-15","current":17.341951,"twenty":14.031188,"median":17.52836,"eighty":32.07012,"marketCap":101901306173},{"date":"2023-12-22","current":16.737591,"twenty":14.031188,"median":17.504184,"eighty":31.887287,"marketCap":98350086772},{"date":"2023-12-29","current":17.206235,"twenty":14.029482,"median":17.486007,"eighty":31.764,"marketCap":101103839360},{"date":"2024-01-05","current":17.914503,"twenty":14.027776,"median":17.48476,"eighty":31.6075,"marketCap":105265619289},{"date":"2024-01-12","current":18.107474,"twenty":14.027776,"median":17.48476,"eighty":31.532333,"marketCap":106399517414},{"date":"2024-01-19","current":18.321651,"twenty":14.024373,"median":17.483513,"eighty":31.465946,"marketCap":107658019728},{"date":"2024-01-26","current":17.013264,"twenty":14.027776,"median":17.475784,"eighty":31.443073,"marketCap":99969941235},{"date":"2024-02-02","current":16.574308,"twenty":14.027776,"median":17.458344,"eighty":31.344417,"marketCap":97390634513},{"date":"2024-02-09","current":16.232638,"twenty":14.027776,"median":17.458344,"eighty":31.344417,"marketCap":91957891851},{"date":"2024-02-16","current":16.138057,"twenty":14.027776,"median":17.458344,"eighty":31.344417,"marketCap":91422093836},{"date":"2024-02-23","current":16.008284,"twenty":14.027776,"median":17.458344,"eighty":31.344417,"marketCap":90686929118},{"date":"2024-03-01","current":15.855313,"twenty":14.029482,"median":17.457598,"eighty":31.337724,"marketCap":89820349813},{"date":"2024-03-08","current":16.198369,"twenty":14.029482,"median":17.457598,"eighty":31.337724,"marketCap":91763758214},{"date":"2024-03-15","current":16.319318,"twenty":14.029482,"median":17.457598,"eighty":31.337724,"marketCap":92448934253},{"date":"2024-03-22","current":16.073021,"twenty":14.029482,"median":17.457598,"eighty":31.337724,"marketCap":91053666683},{"date":"2024-03-28","current":16.055429,"twenty":14.029482,"median":17.457598,"eighty":31.337724,"marketCap":90954004714},{"date":"2024-04-05","current":15.309217,"twenty":14.027776,"median":17.458344,"eighty":31.344417,"marketCap":86726715023},{"date":"2024-04-12","current":15.111111,"twenty":14.027776,"median":17.458344,"eighty":31.344417,"marketCap":85604442650},{"date":"2024-04-19","current":14.563017,"twenty":14.027776,"median":17.458344,"eighty":31.344417,"marketCap":82499489086},{"date":"2024-04-26","current":167.813786,"twenty":14.029482,"median":17.45909,"eighty":31.35376,"marketCap":81389686406},{"date":"2024-05-03","current":167.968051,"twenty":14.029482,"median":17.475896,"eighty":31.454751,"marketCap":81464504564},{"date":"2024-05-10","current":165.891135,"twenty":14.029482,"median":17.490666,"eighty":31.502061,"marketCap":80457200237},{"date":"2024-05-17","current":174.305702,"twenty":14.043532,"median":17.524273,"eighty":31.57906,"marketCap":84538265441},{"date":"2024-05-24","current":169.975478,"twenty":14.043532,"median":17.54896,"eighty":31.623197,"marketCap":82438106839},{"date":"2024-05-31","current":164.60675,"twenty":14.10774,"median":17.565264,"eighty":31.836928,"marketCap":79834273632},{"date":"2024-06-07","current":164.015933,"twenty":14.265245,"median":17.579161,"eighty":32.047548,"marketCap":79547727394},{"date":"2024-06-14","current":163.27099,"twenty":14.274228,"median":17.606597,"eighty":32.082158,"marketCap":79186429964},{"date":"2024-06-21","current":175.935023,"twenty":14.272576,"median":17.621828,"eighty":32.181475,"marketCap":85328486284},{"date":"2024-06-28","current":176.808405,"twenty":14.267619,"median":17.642004,"eighty":32.289819,"marketCap":85752076375},{"date":"2024-07-05","current":171.054361,"twenty":14.267619,"median":17.658975,"eighty":32.499738,"marketCap":82961365187},{"date":"2024-07-12","current":179.736802,"twenty":14.267619,"median":17.687689,"eighty":32.981271,"marketCap":87172349033},{"date":"2024-07-15","current":179.711114,"twenty":14.267619,"median":17.696211,"eighty":33.038453,"marketCap":87159890501},{"date":"2024-08-02","current":196.485179,"twenty":14.529265,"median":17.810595,"eighty":33.095635,"marketCap":95295311956},{"date":"2024-08-09","current":89.28743,"twenty":14.761123,"median":17.860178,"eighty":33.429699,"marketCap":94108951402},{"date":"2024-08-16","current":87.810922,"twenty":15.064446,"median":17.910429,"eighty":56.284205,"marketCap":92552711301},{"date":"2024-08-23","current":89.653604,"twenty":15.441554,"median":17.994613,"eighty":57.705461,"marketCap":94494898947},{"date":"2024-08-30","current":93.846889,"twenty":15.739388,"median":18.052169,"eighty":58.207525,"marketCap":98914620835},{"date":"2024-09-06","current":93.043668,"twenty":15.813085,"median":18.107474,"eighty":58.39978,"marketCap":98068026220},{"date":"2024-09-13","current":98.229166,"twenty":15.851395,"median":18.176723,"eighty":59.168901,"marketCap":103533541455},{"date":"2024-09-20","current":99.10326,"twenty":15.88894,"median":18.219893,"eighty":59.37255,"marketCap":104454835595},{"date":"2024-09-27","current":98.087422,"twenty":15.920691,"median":18.287258,"eighty":59.81346,"marketCap":103384142406},{"date":"2024-10-04","current":99.422185,"twenty":15.979621,"median":18.356937,"eighty":60.090264,"marketCap":104790983457},{"date":"2024-10-11","current":100.012789,"twenty":16.007608,"median":18.435741,"eighty":60.321593,"marketCap":105413479498},{"date":"2024-10-18","current":103.190235,"twenty":16.047512,"median":18.510381,"eighty":60.845545,"marketCap":108762508196},{"date":"2024-10-25","current":104.867549,"twenty":16.062334,"median":18.540053,"eighty":61.800519,"marketCap":110530396951},{"date":"2024-10-31","current":104.288758,"twenty":16.062334,"median":18.540053,"eighty":63.846895,"marketCap":109920350831},{"date":"2024-11-08","current":968.122222,"twenty":16.060766,"median":18.539019,"eighty":65.503766,"marketCap":121983400000},{"date":"2024-11-15","current":911.059905,"twenty":16.060766,"median":18.539019,"eighty":67.314857,"marketCap":114793548088},{"date":"2024-11-22","current":887.816058,"twenty":16.060766,"median":18.539019,"eighty":87.499083,"marketCap":111864823324},{"date":"2024-11-29","current":915.708675,"twenty":16.060766,"median":18.539019,"eighty":88.564531,"marketCap":115379293041},{"date":"2024-12-06","current":923.720384,"twenty":16.060766,"median":18.539019,"eighty":90.934033,"marketCap":116388768385},{"date":"2024-12-13","current":913.730475,"twenty":16.060766,"median":18.539019,"eighty":93.40748,"marketCap":115130039869},{"date":"2024-12-20","current":900.971087,"twenty":16.060766,"median":18.539019,"eighty":95.961249,"marketCap":113522356914},{"date":"2024-12-27","current":933.809203,"twenty":16.060766,"median":18.539019,"eighty":98.094509,"marketCap":117659959559},{"date":"2025-01-03","current":908.784976,"twenty":16.060766,"median":18.539019,"eighty":98.88828,"marketCap":114506906941},{"date":"2025-01-10","current":881.683639,"twenty":16.059197,"median":18.537985,"eighty":99.141058,"marketCap":111092138492},{"date":"2025-01-17","current":906.510046,"twenty":16.059197,"median":18.537985,"eighty":99.880493,"marketCap":114220265794},{"date":"2025-01-24","current":919.071615,"twenty":16.059197,"median":18.537985,"eighty":100.438024,"marketCap":115803023432},{"date":"2025-01-31","current":958.93234,"twenty":16.059197,"median":18.537985,"eighty":102.332679,"marketCap":120825474836},{"date":"2025-02-07","current":969.713529,"twenty":16.09178,"median":18.615892,"eighty":104.116302,"marketCap":122183904620},{"date":"2025-02-14","current":275.113188,"twenty":16.111578,"median":18.662662,"eighty":105.609347,"marketCap":132054330207},{"date":"2025-02-21","current":285.680484,"twenty":16.147709,"median":18.689929,"eighty":162.793199,"marketCap":137126632245},{"date":"2025-02-28","current":290.769403,"twenty":16.147709,"median":18.808017,"eighty":164.216297,"marketCap":139569313325},{"date":"2025-03-07","current":301.06241,"twenty":16.143392,"median":18.87176,"eighty":165.27463,"marketCap":144509957034},{"date":"2025-03-14","current":294.083284,"twenty":16.164977,"median":18.897485,"eighty":166.913912,"marketCap":141159976127},{"date":"2025-03-21","current":274.676641,"twenty":16.17325,"median":18.953832,"eighty":167.968051,"marketCap":131844787583},{"date":"2025-03-28","current":288.401392,"twenty":16.17325,"median":19.023685,"eighty":168.716781,"marketCap":138432668251},{"date":"2025-04-04","current":291.592591,"twenty":16.17325,"median":19.104641,"eighty":171.054361,"marketCap":139964443908},{"date":"2025-04-11","current":263.079356,"twenty":16.173436,"median":19.194795,"eighty":173.515242,"marketCap":126278090686},{"date":"2025-04-17","current":272.389631,"twenty":16.173436,"median":19.238296,"eighty":174.142022,"marketCap":130747023108},{"date":"2025-04-25","current":22.184451,"twenty":16.17325,"median":19.285524,"eighty":176.243276,"marketCap":132330248884},{"date":"2025-05-02","current":21.578375,"twenty":16.17325,"median":19.297177,"eighty":176.243276,"marketCap":128715008924},{"date":"2025-05-09","current":20.470089,"twenty":16.17325,"median":19.297177,"eighty":176.243276,"marketCap":122104082517},{"date":"2025-05-16","current":20.924702,"twenty":16.17325,"median":19.309817,"eighty":176.243276,"marketCap":124815848001},{"date":"2025-05-23","current":22.259345,"twenty":16.17325,"median":19.375544,"eighty":176.243276,"marketCap":132776994375},{"date":"2025-05-30","current":23.170656,"twenty":16.17325,"median":19.403352,"eighty":176.243276,"marketCap":138212964634},{"date":"2025-06-06","current":23.035107,"twenty":16.17325,"median":19.46767,"eighty":176.243276,"marketCap":137404410705},{"date":"2025-06-13","current":23.366682,"twenty":16.17325,"median":19.52123,"eighty":176.243276,"marketCap":139382258008},{"date":"2025-06-20","current":22.522103,"twenty":16.167278,"median":19.629121,"eighty":176.258689,"marketCap":134344345068},{"date":"2025-06-27","current":22.442859,"twenty":16.167278,"median":19.72304,"eighty":176.258689,"marketCap":133871652002},{"date":"2025-07-03","current":23.304121,"twenty":16.167278,"median":19.777574,"eighty":176.258689,"marketCap":139009079271},{"date":"2025-07-11","current":23.885942,"twenty":16.167278,"median":19.874523,"eighty":176.258689,"marketCap":142479641519},{"date":"2025-07-18","current":22.688934,"twenty":16.167278,"median":20.047213,"eighty":176.258689,"marketCap":135339488364},{"date":"2025-07-25","current":23.606501,"twenty":16.167278,"median":20.135073,"eighty":176.258689,"marketCap":140812776497},{"date":"2025-08-01","current":23.416731,"twenty":16.193531,"median":20.515968,"eighty":176.258689,"marketCap":139680800997},{"date":"2025-08-08","current":21.73673,"twenty":16.230379,"median":20.924702,"eighty":176.258689,"marketCap":137180503463},{"date":"2025-08-15","current":23.400545,"twenty":16.265509,"median":21.375144,"eighty":176.258689,"marketCap":147680839142},{"date":"2025-08-22","current":22.834308,"twenty":16.329624,"median":21.49301,"eighty":176.258689,"marketCap":144107315224},{"date":"2025-08-29","current":22.130443,"twenty":16.387413,"median":21.593495,"eighty":176.258689,"marketCap":139665226464},{"date":"2025-09-05","current":22.171731,"twenty":16.4349,"median":21.646285,"eighty":176.274101,"marketCap":139925795917},{"date":"2025-09-12","current":23.172477,"twenty":16.509435,"median":21.73673,"eighty":176.258689,"marketCap":146241503119},{"date":"2025-09-19","current":22.33885,"twenty":16.547758,"median":21.802614,"eighty":176.258689,"marketCap":140980481795},{"date":"2025-09-26","current":21.821765,"twenty":16.572129,"median":22.017164,"eighty":176.258689,"marketCap":137717159606},{"date":"2025-10-03","current":21.737223,"twenty":16.611295,"median":22.028027,"eighty":176.258689,"marketCap":137183612632},{"date":"2025-10-10","current":22.952274,"twenty":16.651672,"median":22.107199,"eighty":176.258689,"marketCap":144851799373},{"date":"2025-10-17","current":23.170511,"twenty":16.731298,"median":22.14224,"eighty":176.258689,"marketCap":146229095050},{"date":"2025-10-24","current":23.738714,"twenty":16.778677,"median":22.171731,"eighty":176.258689,"marketCap":149815027037},{"date":"2025-10-31","current":18.120983,"twenty":16.795866,"median":22.184451,"eighty":176.258689,"marketCap":146961171131},{"date":"2025-11-07","current":18.898002,"twenty":16.795866,"median":22.144649,"eighty":176.258689,"marketCap":153262800000},{"date":"2025-11-14","current":19.153279,"twenty":16.795866,"median":22.11668,"eighty":176.258689,"marketCap":155333088799},{"date":"2025-11-21","current":19.121152,"twenty":16.795866,"median":22.040002,"eighty":176.258689,"marketCap":155072546078},{"date":"2025-11-28","current":19.254246,"twenty":16.795866,"median":21.968279,"eighty":176.258689,"marketCap":156151937350},{"date":"2025-12-05","current":18.758586,"twenty":16.795866,"median":21.821765,"eighty":176.258689,"marketCap":152132135372},{"date":"2025-12-12","current":18.848845,"twenty":16.795866,"median":21.756377,"eighty":176.258689,"marketCap":152864136349},{"date":"2025-12-19","current":18.582658,"twenty":16.795866,"median":21.664107,"eighty":176.258689,"marketCap":150705353805},{"date":"2025-12-26","current":19.22518,"twenty":16.795866,"median":21.623369,"eighty":176.258689,"marketCap":155916208222},{"date":"2026-01-02","current":18.776944,"twenty":16.795866,"median":21.579916,"eighty":176.258689,"marketCap":152281016927},{"date":"2026-01-09","current":18.460273,"twenty":16.795866,"median":21.456002,"eighty":176.258689,"marketCap":149712810107},{"date":"2026-01-16","current":18.550532,"twenty":16.795866,"median":21.131806,"eighty":176.258689,"marketCap":150444811084},{"date":"2026-01-23","current":20.061988,"twenty":16.795866,"median":20.904605,"eighty":176.258689,"marketCap":162702725760},{"date":"2026-01-30","current":21.348562,"twenty":16.795866,"median":20.79477,"eighty":176.258689,"marketCap":173136841389},{"date":"2026-02-06","current":22.85084,"twenty":16.795866,"median":20.79477,"eighty":174.722564,"marketCap":185320315287},{"date":"2026-02-13","current":22.1325,"twenty":16.795866,"median":20.79477,"eighty":173.804449,"marketCap":188347573567},{"date":"2026-02-20","current":22.031904,"twenty":16.795866,"median":20.79477,"eighty":172.268409,"marketCap":187491504627},{"date":"2026-02-27","current":20.972859,"twenty":16.795866,"median":20.79477,"eighty":169.624219,"marketCap":178479029310},{"date":"2026-03-06","current":21.172712,"twenty":16.795866,"median":20.79477,"eighty":168.328001,"marketCap":180179775433},{"date":"2026-03-13","current":21.182923,"twenty":16.795866,"median":20.79477,"eighty":167.61653,"marketCap":180266674870},{"date":"2026-03-20","current":20.584824,"twenty":16.795866,"median":20.611082,"eighty":165.952785,"marketCap":175176850706},{"date":"2026-03-27","current":19.964567,"twenty":16.795866,"median":20.470089,"eighty":164.868764,"marketCap":169898469139},{"date":"2026-04-02","current":20.46339,"twenty":16.795866,"median":20.259289,"eighty":164.031346,"marketCap":174143448423},{"date":"2026-04-10","current":20.72447,"twenty":16.795866,"median":20.244608,"eighty":117.698348,"marketCap":176365235827}],"updateTime":1776092054571},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GILD\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1172994317","title":"吉利德科學正與Galapagos就收購的Ouro Medicines資產展開研發合作深入談判","url":"https://stock-news.laohu8.com/highlight/detail?id=1172994317","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172994317?lang=zh_tw&edition=fundamental","pubTime":"2026-03-24 06:16","pubTimestamp":1774304171,"startTime":"0","endTime":"0","summary":"吉利德科学目前正与Galapagos公司进行深入磋商，双方拟就吉利德收购的Ouro Medicines资产展开潜在的研发合作。此次谈判标志着两家公司在创新药物开发领域的战略协同进入新阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0882574055.USD","LU1571399168.USD","LU0109394709.USD","BK4585","LU1934455863.HKD","LU2468319806.SGD","LU1057294990.SGD","BK4578","BK4583","LU1061106388.HKD","LU0823416689.USD","LU1934455194.USD","IE00BKVL7J92.USD","BK4568","LU0289739699.SGD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","LU1037948541.HKD","LU1037948897.HKD","LU1839511570.USD","LU2112291526.USD","LU0965509101.SGD","IE0002270589.USD","SG9999015986.USD","SG9999015978.USD","GILD","BK4532","LU0122379950.USD","LU0320765992.SGD","LU0965509283.SGD","LU1674673428.USD","LU2089984988.USD","BK4139","IE00BZ1G4Q59.USD","LU1674673691.USD","LU2087621335.USD","LU0889565916.HKD","LU1778281490.HKD","BK4588","LU1066051498.USD","SG9999015952.SGD","LU2324357040.USD","BK4550","LU0058720904.USD","LU1934455277.USD","IE00B7SZLL34.SGD","LU1430594728.SGD","LU0114720955.EUR","LU0861579265.USD","LU1066053197.SGD","SG9999015945.SGD","IE00BSNM7G36.USD","LU0965508806.USD","BK4566","LU0965509010.AUD","LU1585245621.USD","LU0234570918.USD","IE00B3T34201.USD","LU1023059063.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145865834","title":"吉利德科學將收購Ouro Medicines，推進其首創的T細胞銜接器項目以治療自身免疫性疾病","url":"https://stock-news.laohu8.com/highlight/detail?id=1145865834","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145865834?lang=zh_tw&edition=fundamental","pubTime":"2026-03-24 06:16","pubTimestamp":1774304170,"startTime":"0","endTime":"0","summary":"吉利德科学已达成协议，将收购Ouro Medicines公司，此举旨在加速推进其首创的T细胞衔接器项目，该项目的重点在于开发针对自身免疫性疾病的创新疗法。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1674673691.USD","LU1023059063.AUD","IE00BSNM7G36.USD","LU0823416689.USD","BK4550","LU1571399168.USD","LU1934455277.USD","LU0289739699.SGD","LU1430594728.SGD","BK4566","LU0861579265.USD","LU0965509010.AUD","LU1061106388.HKD","SG9999015978.USD","LU0122379950.USD","LU2112291526.USD","IE00B19Z3581.USD","LU1037948541.HKD","LU2468319806.SGD","BK4532","LU1066053197.SGD","LU1585245621.USD","LU0965508806.USD","LU0320765992.SGD","LU0109394709.USD","LU1066051498.USD","BK4585","BK4578","GILD","IE00B19Z3B42.SGD","LU1778281490.HKD","LU1037948897.HKD","LU1934455194.USD","LU2089984988.USD","BK4139","LU1934455863.HKD","BK4568","LU0058720904.USD","LU0965509101.SGD","LU0114720955.EUR","IE00B3T34201.USD","IE00BKVL7J92.USD","LU0965509283.SGD","LU0234570918.USD","LU1057294990.SGD","LU2324357040.USD","SG9999015952.SGD","IE00B7SZLL34.SGD","SG9999015945.SGD","LU1674673428.USD","BK4588","BK4583","LU0889565916.HKD","LU1839511570.USD","IE00BZ1G4Q59.USD","LU0882574055.USD","LU2087621335.USD","IE0002270589.USD","SG9999015986.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621088819","title":"據英國《金融時報》報導，吉利德接近以最高20億美元收購生物技術公司Ouro Medicines","url":"https://stock-news.laohu8.com/highlight/detail?id=2621088819","media":"路透中文","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621088819?lang=zh_tw&edition=fundamental","pubTime":"2026-03-24 00:42","pubTimestamp":1774284157,"startTime":"0","endTime":"0","summary":"据英国《金融时报》报导，吉利德接近以最高20亿美元收购生物技术公司Ouro Medicines路透3月23日 - 英国《金融时报》周一援引知情人士的话报导称，吉利德科学公司GILD.O即将以最高20亿美元的价格收购生物技术公司Ouro Medicines。 (为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nL4T40B1JO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0114720955.EUR","LU1674673691.USD","BK4588","LU1585245621.USD","LU0289739699.SGD","IE00B19Z3581.USD","IE00BSNM7G36.USD","SG9999015945.SGD","BK4585","LU0965509101.SGD","SG9999015952.SGD","LU1066051498.USD","LU0234570918.USD","BK4532","LU1934455863.HKD","BK4568","LU0823416689.USD","LU1057294990.SGD","LU0320765992.SGD","LU1037948541.HKD","LU1839511570.USD","LU0122379950.USD","LU0965509010.AUD","LU1934455194.USD","GILD","IE0002270589.USD","BK4566","LU2468319806.SGD","BK4578","LU0058720904.USD","LU1430594728.SGD","LU2089984988.USD","LU1778281490.HKD","IE00B3T34201.USD","SG9999015978.USD","IE00BZ1G4Q59.USD","LU2324357040.USD","LU1061106388.HKD","LU0889565916.HKD","LU1571399168.USD","LU2087621335.USD","IE00BKVL7J92.USD","IE00B19Z3B42.SGD","IE00B7SZLL34.SGD","LU1066053197.SGD","LU0882574055.USD","LU1037948897.HKD","LU0861579265.USD","LU2112291526.USD","LU0965509283.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175690757","title":"吉利德科學與Ouro Medicines談判進入後期階段 交易有望近日公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1175690757","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175690757?lang=zh_tw&edition=fundamental","pubTime":"2026-03-24 00:37","pubTimestamp":1774283835,"startTime":"0","endTime":"0","summary":"据知情人士透露，生物制药巨头吉利德科学与生物技术公司Ouro Medicines的并购谈判已进入关键阶段。双方正就最终条款进行磋商，若谈判顺利，这项备受业界关注的交易可能在未来数日内正式对外公告。此次潜在收购将强化吉利德在创新疗法领域的战略布局。市场观察人士指出，此举延续了吉利德近年来通过并购加速创新的战略路径。随着谈判进入收官阶段，两家公司股价近日均呈现波动上行态势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU0882574055.USD","IE00BKVL7J92.USD","LU0965509010.AUD","LU2112291526.USD","SG9999015978.USD","BK4566","LU0889565916.HKD","LU1674673691.USD","LU0965509101.SGD","BK4578","SG9999015986.USD","LU1934455277.USD","SG9999015945.SGD","LU2087621335.USD","IE00B19Z3B42.SGD","IE00BSNM7G36.USD","LU0320765992.SGD","LU1066051498.USD","LU1934455863.HKD","LU1934455194.USD","LU1037948541.HKD","LU2468319806.SGD","BK4583","LU0122379950.USD","IE00B19Z3581.USD","IE00BZ1G4Q59.USD","BK4550","BK4532","LU0114720955.EUR","LU1674673428.USD","LU1839511570.USD","LU0289739699.SGD","BK4568","IE0002270589.USD","LU0965508806.USD","IE00B7SZLL34.SGD","LU0965509283.SGD","LU1778281490.HKD","LU0823416689.USD","LU0861579265.USD","LU1037948897.HKD","LU1066053197.SGD","LU2089984988.USD","GILD","LU0234570918.USD","LU1430594728.SGD","LU1585245621.USD","IE00B3T34201.USD","SG9999015952.SGD","BK4139","LU0058720904.USD","LU1057294990.SGD","LU1061106388.HKD","LU1571399168.USD","LU1023059063.AUD","BK4588","LU2324357040.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102792638","title":"吉利德科學將以約15億美元現金預付款收購Ouro，若臨床試驗達標還將額外支付至少5億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1102792638","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102792638?lang=zh_tw&edition=fundamental","pubTime":"2026-03-24 00:37","pubTimestamp":1774283833,"startTime":"0","endTime":"0","summary":"吉利德科学将向私人控股的Ouro公司投资者支付约15亿美元现金作为预付款。此外，若达成特定临床试验里程碑，吉利德科学还将额外支付至少5亿美元资金。该交易结构凸显了生物医药行业对创新疗法的高估值趋势，资金支付与研发进展深度绑定的模式也成为当前并购交易的新特征。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015945.SGD","LU0114720955.EUR","LU2112291526.USD","LU1061106388.HKD","LU1934455194.USD","LU1934455277.USD","LU2087621335.USD","IE00B7SZLL34.SGD","LU2468319806.SGD","LU2324357040.USD","BK4578","LU1571399168.USD","IE00BZ1G4Q59.USD","BK4583","GILD","LU0289739699.SGD","LU0965509101.SGD","BK4568","LU0889565916.HKD","SG9999015978.USD","LU0965508806.USD","LU1066051498.USD","LU1037948897.HKD","LU1066053197.SGD","BK4532","BK4566","LU0122379950.USD","LU1839511570.USD","SG9999015952.SGD","LU1674673691.USD","LU1778281490.HKD","LU1934455863.HKD","LU0058720904.USD","LU1430594728.SGD","IE00B3T34201.USD","LU1057294990.SGD","LU2089984988.USD","IE0002270589.USD","LU1023059063.AUD","LU0861579265.USD","BK4588","BK4139","IE00B19Z3581.USD","BK4585","LU0234570918.USD","LU0320765992.SGD","LU0882574055.USD","LU0823416689.USD","LU0965509283.SGD","IE00BKVL7J92.USD","LU1585245621.USD","SG9999015986.USD","BK4550","LU0109394709.USD","LU0965509010.AUD","LU1037948541.HKD","IE00B19Z3B42.SGD","IE00BSNM7G36.USD","LU1674673428.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621670575","title":"BUZZ-Xilio股價因意外季度盈利而上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2621670575","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621670575?lang=zh_tw&edition=fundamental","pubTime":"2026-03-23 20:45","pubTimestamp":1774269954,"startTime":"0","endTime":"0","summary":"3月23日 - ** 药物开发商Xilio Therapeutics XLO.O股价盘前上涨3.18%至8.11美元 ** 该公司公布第四季度每股利润为81美分，而分析师此前预期为每股亏损1.68美元，数据由LSEG编制  ** 该公司第四季度营收为1,370万美元，高于预期的790万美元。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nL4T40B145:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV","LU0211327993.USD","LU1244550494.USD","LU1839511570.USD","LU1551013342.USD","LU0545039389.USD","LU0795875169.SGD","LU1551013425.SGD","BK4532","BK4583","IE00B2B36J28.USD","IE00B3PB1722.GBP","LU0823416689.USD","LU0985320562.USD","LU0689472784.USD","IE00BSNM7G36.USD","LU0124676726.USD","BK4559","LU1674673428.USD","LU2129689605.HKD","LU0661504455.SGD","LU2023251221.USD","LU1023059063.AUD","LU0057025933.USD","LU1983299246.USD","LU0912757837.SGD","GILD","LU1066051498.USD","LU0882574055.USD","LU2112291526.USD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","LU2089284900.SGD","LU0198837287.USD","LU0511384066.AUD","IE00B3T34201.USD","LU1074936037.SGD","BK4534","LU1003077747.HKD","XLO","LU0069063385.USD","IE00BGHQF631.EUR","BK4566","LU2237443549.SGD","LU0310800379.SGD","SG9999015952.SGD","SG9999015978.USD","LU1674673691.USD","IE00BZ1G4Q59.USD","BK4578"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620225813","title":"吉利德科學(GILD.US)CD19/CD20 CAR-T細胞療法啓動III期臨床","url":"https://stock-news.laohu8.com/highlight/detail?id=2620225813","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620225813?lang=zh_tw&edition=fundamental","pubTime":"2026-03-19 21:12","pubTimestamp":1773925932,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，3月18日，美国临床试验收录网站显示，吉利德科学旗下公司Kite Pharma启动了KITE-753的首个III期临床试验。KITE-753是一款靶向CD19和CD20的双顺反子自体CAR-T细胞疗法。研究的主要终点是第6个月实现完全缓解的患者比例和36个月内的无事件生存期。结果显示，剂量3队列，在14例未接受过CAR-T细胞疗法治疗的患者中，11例实现CR，CR率为79%;总人群，在20例未接受过CAR-T细胞疗法治疗的患者中，14例实现CR，CR率为70%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1416170.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0882574055.USD","SG9999015978.USD","LU2112291526.USD","SG9999015986.USD","BK4588","BK4134","LU0823416689.USD","SG9999015945.SGD","LU0234570918.USD","LU1674673428.USD","LU0965509101.SGD","SG9999015952.SGD","LU0058720904.USD","GILD","LU0114720955.EUR","LU1066051498.USD","BK4583","LU0861579265.USD","LU0109394709.USD","LU0289739699.SGD","LU1037948541.HKD","LU1934455863.HKD","LU1674673691.USD","BK4022","LU0965509283.SGD","LU1023059063.AUD","BK4532","III","LU1430594728.SGD","IE00BKVL7J92.USD","LU1585245621.USD","LU1839511570.USD","CAR","LU2089984988.USD","IE0002270589.USD","LU0965508806.USD","LU1066053197.SGD","LU2087621335.USD","LU1061106388.HKD","BK4568","IE00B3T34201.USD","LU0965509010.AUD","IE00B19Z3581.USD","LU0889565916.HKD","LU1037948897.HKD","BK4139","IE00B19Z3B42.SGD","IE00BZ1G4Q59.USD","LU1571399168.USD","LU0122379950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620096254","title":"吉利德科學(GILD)股票3月18日盤中下跌3.37%：投資者必看的核心信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2620096254","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620096254?lang=zh_tw&edition=fundamental","pubTime":"2026-03-18 22:16","pubTimestamp":1773843388,"startTime":"0","endTime":"0","summary":"• 吉利德 2026 年 Yeztugo 销售预测低于分析师预期。\n• 吉利德 2026 年每股收益（EPS）指引处于分析师预测范围的低端。\n• 公司高管减持股份，可能对股价构成压力。","market":"nz","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/Market-Movers/261694908-market-movers-gild-20260318","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ1G4Q59.USD","LU0114720955.EUR","BK4139","LU1585245621.USD","LU1430594728.SGD","LU1934455194.USD","IE00B19Z3B42.SGD","LU1778281490.HKD","LU0289739699.SGD","BK4578","LU2112291526.USD","SG9999015945.SGD","LU0234570918.USD","LU1839511570.USD","LU0122379950.USD","IE00BSNM7G36.USD","BK4585","LU0109394709.USD","LU2087621335.USD","LU0320765992.SGD","SG9999015978.USD","BK4583","IE00B7SZLL34.SGD","IE00B19Z3581.USD","LU1066053197.SGD","LU2324357040.USD","LU0965509283.SGD","GILD","LU0058720904.USD","LU0965509010.AUD","LU0882574055.USD","LU1061106388.HKD","LU1037948897.HKD","LU0861579265.USD","LU1934455863.HKD","SG9999015986.USD","SG9999015952.SGD","LU0823416689.USD","LU2089984988.USD","LU0889565916.HKD","LU1066051498.USD","LU1571399168.USD","LU1934455277.USD","IE0002270589.USD","BK4566","LU1057294990.SGD","LU0965508806.USD","LU1023059063.AUD","LU0965509101.SGD","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620425366","title":"埃斯瓦提尼開始使用來那卡韋遏制艾滋病毒傳播","url":"https://stock-news.laohu8.com/highlight/detail?id=2620425366","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620425366?lang=zh_tw&edition=fundamental","pubTime":"2026-03-17 18:32","pubTimestamp":1773743541,"startTime":"0","endTime":"0","summary":"埃斯瓦提尼开始使用来那卡韦遏制艾滋病毒传播Lunga Masuku路透姆巴巴内3月17日 - 埃斯瓦提尼周三正式推出了新型艾滋病毒预防药物来那卡韦，加入了少数几个国家的行列，并宣布自12月以来已有2,000名斯威士兰人接受了注射。迄今为止，该药物的配制国美国和其他七个艾滋病毒流行率较高的非洲国家已经引入了该药物。埃斯瓦提尼是南非的一个小王国，前身是斯威士兰。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nL4T4050V5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0965509283.SGD","LU2087621335.USD","LU1674673428.USD","LU1066051498.USD","IE00BSNM7G36.USD","LU1066053197.SGD","BK4566","SG9999015952.SGD","BK4585","LU2468319806.SGD","IE00BKVL7J92.USD","SG9999015978.USD","IE00B7SZLL34.SGD","IE00B19Z3B42.SGD","LU1037948897.HKD","LU0114720955.EUR","LU0965508806.USD","IE00BZ1G4Q59.USD","BK4583","LU0965509101.SGD","LU1934455277.USD","LU2112291526.USD","LU1037948541.HKD","BK4578","LU0320765992.SGD","BK4139","LU0234570918.USD","LU1571399168.USD","SG9999015986.USD","LU1839511570.USD","LU2324357040.USD","LU0058720904.USD","BK4588","LU0965509010.AUD","LU0882574055.USD","SG9999015945.SGD","LU1023059063.AUD","LU1057294990.SGD","LU1061106388.HKD","GILD","IE00B19Z3581.USD","BK4532","LU1934455863.HKD","IE0002270589.USD","LU1674673691.USD","LU1585245621.USD","LU0109394709.USD","LU1778281490.HKD","LU2089984988.USD","LU1430594728.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618188727","title":"華爾街機構的錢都去哪了？美銀最新報告：全在AI裏，Palantir(PLTR.US)、博通(AVGO.US)排隊吸金","url":"https://stock-news.laohu8.com/highlight/detail?id=2618188727","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618188727?lang=zh_tw&edition=fundamental","pubTime":"2026-03-12 14:43","pubTimestamp":1773297797,"startTime":"0","endTime":"0","summary":"博通、Arista Networks、安费诺等AI产业链及半导体关联企业，机构持股同样大幅增长，凸显机构资金正全面转向AI基础设施与数据技术领域。Meta、奈飞等大型通信服务企业，同样获得机构新增持仓。前五名其余个股为西部数据、博通、GE Vernova，均为“持有”评级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1413031.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2720916845.USD","LU1003077747.HKD","IE00BJJMRY28.SGD","LU1551013425.SGD","IE00BQXX3D17.EUR","LU0109391861.USD","LU1127390331.HKD","LU0203201768.USD","LU0234572021.USD","LU0274383776.USD","IE00BFSS7M15.SGD","LU1069344957.HKD","LU0965509283.SGD","LU2430703251.USD","LU2125154778.USD","LU1923623000.USD","LU0708995401.HKD","LU2357305700.SGD","LU1988902786.USD","IE00BZ9MQY76.HKD","LU0011850046.USD","LU0444973449.USD","LU1670711123.USD","BK4551","LU0320765646.SGD","LU0048584097.USD","LU2242650005.HKD","BK4512","LU0784383803.USD","AVS","LU0234570918.USD","LU1153585028.USD","LU2458330243.SGD","LU1691799644.USD","LU0320765059.SGD","LU1935042488.USD","LU1814569148.SGD","LU0472753341.HKD","LU0348723411.USD","LU2420271590.USD","LU2473716301.USD","LU0097036916.USD","SG9999015986.USD","IE00BBT3K403.USD","LU2543165471.USD","LU1712237335.SGD","LU1732799900.SGD","PTIR","LU0476273544.USD","LU2592432038.USD","LU1934455194.USD","LU1992135472.HKD","GILD","LU2279689827.SGD","LU0289961442.SGD","BK4547","IE00BMPRXN33.USD","IE00B1BXHZ80.USD","LU1720051108.HKD","LU2487616109.SGD","LU2463028550.USD","LU1804176565.USD","LU0868494708.USD","BK4575","LU2505996509.AUD","LU0820561818.USD","LU0069063385.USD","LU2168564222.USD","LU1301847155.USD","LU1242518857.USD","IE00BLSP4452.SGD","IE00B775H168.HKD","LU1778281490.HKD","LU0353189680.USD","LU2360106780.USD","LU2347655073.USD","LU2860962120.EUR","LU2092937221.SGD","PLTR","LU2168564065.EUR","LU0689472784.USD","LU1868836757.USD","LU2237957902.USD","IE00B4JS1V06.HKD","SGXZ23171101.USD","LU0861579265.USD","LU0053666078.USD","LU1868837300.USD","IE00BQXX3F31.USD","LU1642822529.SGD","LU2087625088.SGD","BK4543","IE00BWXC8680.SGD","IE00BGHQDM52.EUR","LU2213496289.HKD","SGXZ99366536.SGD","LU0203202063.USD","LU2237957811.SGD","LU0225283273.USD","IE00B19Z9Z06.USD","LU0726765562.USD","LU1992135399.USD","AVGW","IE00BLSP4239.USD","IE00BVYPNQ40.USD","LU2361045086.USD","LU0154236417.USD","LU1037948897.HKD","LU2361044865.SGD","LU0006306889.USD","LU1868837136.USD","LU2250418816.HKD","IE00BZ1G4Q59.USD","IE0009356076.USD","BK4588","LU2065170008.USD","LU2264538146.SGD","LU0061474960.USD","IE00BK4W5M84.HKD","IE00B3PB1722.GBP","LU2063271972.USD","BK4613","LU0786609619.USD","IE00B894F039.SGD","LU0820562030.AUD","LU0949170426.SGD","LU2322448791.USD","IE00BJTD4N35.SGD","LU0957808578.USD","IE00BMCWC346.EUR","LU2746668461.USD","LU0957791311.USD","LU2237443622.USD","SG9999015978.USD","LU2023250843.SGD","LU0170899867.USD","IE0034235303.USD","LU2133065610.SGD","LU0466842654.USD","IE00BDGV0183.EUR","LU0316494557.USD","LU0943347566.SGD","LU0965508806.USD","IE00BVYPNP33.GBP","LU1674673428.USD","LU0965509010.AUD","LU2237443465.HKD","LU0056508442.USD","BK4581","LU1868836591.USD","LU0640476718.USD","LU0210536198.USD","LU0289739343.SGD","LU1914381329.SGD","LU2237443382.USD","LU2125154935.USD","LU0081259029.USD","LU1815333072.USD","LU2896262040.SGD","LU2756315664.SGD","LU0979878070.USD","LU1037948541.HKD","LU2322448957.HKD","IE00BN29S564.USD","LU2298321311.HKD","LU0256863811.USD","IE0005OL40V9.USD","LU2360108059.USD","LU1244550577.SGD","LU1951200564.SGD","LU2764263039.SGD","LU0949170772.SGD","LU0642271901.SGD","BK4598","LU0096364046.USD","LU1868836914.USD","LU2361044949.HKD","IE0004445239.USD","LU1917777945.USD","AVGX","LU2461242641.AUD","LU2471134523.USD","PLTI","LU0215105999.USD","LU1720051017.SGD","LU2237443895.HKD","LU1162221912.USD","LU1244550494.USD","IE00BN8TJ469.HKD","LU2764263203.CNY","LU0345770993.USD","LU2746668974.SGD","LU1803068979.SGD","LU0345768153.USD","IE00BFSS8Q28.SGD","LU1232071149.USD","LU2347655156.SGD","LU2242649171.HKD","LU0203345920.USD","LU2471134796.USD","LU1551013342.USD","LU2236285917.USD","LU2054465674.USD","LU0157215616.USD","LU0354030511.USD","BK4612","LU0187121727.USD","LU0256863902.USD","LU0661504455.SGD","LU0672654240.SGD","LU2355687059.USD","LU2265009873.SGD","LU2106854487.HKD","LU0096362180.USD","LU2065169927.USD","LU0444971666.USD","SG9999001424.SGD","LU2360032135.SGD","LU1366192091.USD","LU1366333091.USD","LU0210533765.USD","LU0210528500.USD","IE00BVYPNV92.GBP","LU2430703178.SGD","LU2041044095.USD","LU0889565833.HKD","LU1935042215.USD","SGXZ81514606.USD","LU1670627923.USD","LU0057025933.USD","APH","LU0109392836.USD","PLTG","IE00B7KXQ091.USD","IE00BGHQF631.EUR","LU1861558580.USD","LU0868494617.USD","PLTW","LU0323591593.USD","LU1629891620.HKD","LU1242518931.SGD","IE00B3S45H60.SGD","LU0784385840.USD","PLTA","LU2065171402.SGD","LU0823434740.USD","LU2247934214.USD","IE00BJLML261.HKD","LU2168564495.EUR","LU0719512351.SGD","LU0417517546.SGD","LU0985320562.USD","LU2108987350.USD","AVGU","LU0912757837.SGD","LU1267930730.SGD","LU1064131342.USD","IE00BQXX3C00.GBP","SG9999003800.SGD","IE00B42XCP33.USD","BK4141","LU0795875086.SGD","LU2089985449.USD","LU0124676726.USD","LU2286300806.USD","LU0795875169.SGD","LU0251132253.USD","LU0965509101.SGD","LU0784385170.HKD","LU2272731782.SGD","LU1670710588.SGD","LU2168563687.JPY","IE00BKVL7J92.USD","SG9999011175.SGD","PLTZ","PLTD","LU0545039389.USD","LU0080751232.USD","LU1280957306.USD","IE0034235188.USD","SGXZ51526630.SGD","LU2023250504.SGD","LU1670628061.USD","LU0511384066.AUD","SG9999002224.SGD","LU0345770308.USD","LU0553294199.USD","LU0683600562.USD","LU0345768740.USD","BK4515","LU2237438978.USD","LU1974910355.USD","SG9999002232.USD","IE00BYV24P56.USD","LU1934455863.HKD","LU2756315318.SGD","LU0784384876.USD","SG9999004303.SGD","BK4585","PLTY","LU1989764748.USD","LU0738911758.USD","PLTU","LU2211814178.USD","GEV","LU1935043023.USD","PLYY","LU0061475181.USD","LU1548497426.USD","IE00BMPRXR70.SGD","IE00BKDWB100.SGD","LU0238689110.USD","LU2505996681.GBP","LU2458330169.SGD","LU2750360997.AUD","BK4605","LU1815336760.USD","LU2244417387.USD","BK4554","LU2471134952.CNY","LU2417539215.USD","LU1934455277.USD","AVGG","LU0198837287.USD","LU1935042991.SGD","LU0823434583.USD","LU0787776722.HKD","LU2211815571.USD","IE00BJTD4V19.USD","LU1035775433.USD","LU1670710661.SGD","LU2764262908.HKD","LU0964807845.USD","LU1316542783.SGD","LU2462157665.USD","LU2065171311.SGD","LU1989764664.SGD","IE00B19Z9P08.USD","AVGO","BK4566","LU2602419157.SGD","LU0127658192.USD","LU2272731865.HKD","LU2456880835.USD","BK4023","LU0082616367.USD","LU0106261372.USD","LU1670711040.USD","IE00B775SV38.USD","BK4533","LU0345769128.USD","LU0942090050.USD","LU2430703095.HKD","LU0354030438.USD","SG9999001440.SGD","LU1732800096.USD","LU2083900584.USD","IE0004445015.USD","LU1674673691.USD","LU1145028129.USD","LU2237443549.SGD","PLT","IE00BJJMRX11.SGD","ANET","IE00BMPRXQ63.HKD","IE00BVYPNW00.USD","IE00B1XK9C88.USD","LU1861559042.SGD","LU1852331112.SGD","AVL","LU2237443978.SGD","LU0203347892.USD","LU0353189763.USD","IE0001KFT4U8.USD","LU2023250330.USD","LU1623119135.USD","IE00BKPKM429.USD","LU2168564149.EUR","PLOO","LU0689626769.HKD","LU0345769631.USD","LU2750360641.GBP","SG9999015945.SGD","LU2471134879.HKD","LU2931357623.SGD","LU1935043536.SGD","SG9999015952.SGD","IE00B5949003.HKD","LU0079474960.USD","LU2272731600.USD","LU2403377893.USD","LU1244550221.USD","LU1951198990.SGD","IE00BK4W5L77.USD","LU1323610961.USD","LU0820561909.HKD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2617652713","title":"吉利德科學盤中異動 早盤股價大跌3.00%報143.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2617652713","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617652713?lang=zh_tw&edition=fundamental","pubTime":"2026-03-06 00:14","pubTimestamp":1772727296,"startTime":"0","endTime":"0","summary":"北京时间2026年03月06日00时14分，吉利德科学股票出现异动，股价急速下跌3.00%。截至发稿，该股报143.78美元/股，成交量120.246万股，换手率0.10%，振幅1.99%。吉利德科学股票所在的制药行业中，整体跌幅为2.25%。吉利德科学公司简介：吉利德科学开发和销售治疗和预防危及生命的传染病的疗法，其投资组合的核心集中在艾滋病毒和乙型肝炎和丙型肝炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306001457a6a76b37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306001457a6a76b37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1061106388.HKD","LU0289739699.SGD","LU2112291526.USD","BK4585","BK4532","IE00B19Z3B42.SGD","LU0882574055.USD","LU1934455863.HKD","BK4550","BK4568","LU0965508806.USD","IE00B7SZLL34.SGD","BK4139","LU0114720955.EUR","SG9999015952.SGD","LU1066051498.USD","IE00BZ1G4Q59.USD","IE0002270589.USD","IE00B3T34201.USD","LU2087621335.USD","GILD","BK4578","LU0861579265.USD","LU1674673428.USD","LU1934455194.USD","LU2468319806.SGD","LU1585245621.USD","LU2324357040.USD","LU0965509010.AUD","LU0965509101.SGD","LU1023059063.AUD","LU1674673691.USD","SG9999015986.USD","SG9999015978.USD","LU0234570918.USD","LU1037948897.HKD","LU1057294990.SGD","LU1839511570.USD","BK4583","LU0122379950.USD","LU0320765992.SGD","BK4588","LU1430594728.SGD","LU1037948541.HKD","IE00BKVL7J92.USD","LU0109394709.USD","LU1778281490.HKD","SG9999015945.SGD","LU0823416689.USD","IE00BSNM7G36.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617518382","title":"南非尋求在當地生產吉利德公司的艾滋病預防藥物","url":"https://stock-news.laohu8.com/highlight/detail?id=2617518382","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617518382?lang=zh_tw&edition=fundamental","pubTime":"2026-03-05 14:00","pubTimestamp":1772690454,"startTime":"0","endTime":"0","summary":"南非寻求在当地生产吉利德公司的艾滋病预防药物南非旨在在全国和地区范围内提高艾滋病预防药物的可及性专家称，来那卡韦有助于终结长达44年的流行病撒哈拉以南非洲仍是艾滋病疫情的中心地带Jennifer Rigby. 路透伦敦3月5日 - 南非正在要求当地制药商启动程序，在国内生产吉利德科学公司的长效艾滋病预防药物来那卡韦，以推动该药物在最需要的地区实现本地化生产。南非有几家公司已经开始生产艾滋病治疗药物或无菌注射剂，如 Aspen Pharmacare 公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nL4T3ZT0JG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4578","LU1585245621.USD","IE00B3T34201.USD","LU1037948541.HKD","BK4568","LU0109394709.USD","LU0965508806.USD","BK4583","LU0114720955.EUR","LU1066051498.USD","LU0965509010.AUD","LU2089984988.USD","IE00BKVL7J92.USD","LU0234570918.USD","BK4585","LU1571399168.USD","LU0965509101.SGD","BK4550","LU0320765992.SGD","LU1023059063.AUD","LU0965509283.SGD","IE00BZ1G4Q59.USD","LU1430594728.SGD","GILD","LU0882574055.USD","LU0058720904.USD","LU0823416689.USD","LU1061106388.HKD","LU0289739699.SGD","LU1066053197.SGD","SG9999015952.SGD","LU2324357040.USD","BK4139","LU1057294990.SGD","SG9999015945.SGD","LU2087621335.USD","LU0122379950.USD","SG9999015986.USD","LU1778281490.HKD","LU0889565916.HKD","LU2112291526.USD","IE00B19Z3B42.SGD","LU1674673691.USD","LU1839511570.USD","LU2468319806.SGD","LU1037948897.HKD","BK4532","LU1674673428.USD","IE0002270589.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171545020","title":"吉利德高管稱Anito-Cel有望覆蓋「高達200億美元」多發性骨髓瘤市場機遇，考慮一線治療應用——TD Cowen會議","url":"https://stock-news.laohu8.com/highlight/detail?id=1171545020","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171545020?lang=zh_tw&edition=fundamental","pubTime":"2026-03-04 00:40","pubTimestamp":1772556015,"startTime":"0","endTime":"0","summary":"在TD Cowen会议上，吉利德科学的高管透露，若将Anito-Cel应用于一线治疗，该疗法有望覆盖多发性骨髓瘤领域“高达200亿美元”的市场机遇。\n这一表态凸显了Anito-Cel在拓展治疗窗口方面的巨大潜力，特别是其在早期治疗阶段可能带来的商业价值。多发性骨髓瘤作为一种恶性血液肿瘤，一线治疗市场的规模庞大，Anito-Cel若能成功切入，将显著提升吉利德在肿瘤治疗领域的竞争力。\n值得注意的是，这一评估基于对现有市场格局和未满足临床需求的深入分析。随着细胞疗法在血液肿瘤领域的不断突破，Anito-Cel的商业前景备受关注。吉利德的战略布局也反映出其对创新疗法长期价值的坚定信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0965509101.SGD","IE00B3T34201.USD","LU0234570918.USD","LU0861579265.USD","IE00BZ1G4Q59.USD","BK4532","LU1037948897.HKD","LU0122379950.USD","BK4585","BK4139","LU2468319806.SGD","LU0823416689.USD","BK4568","LU1061106388.HKD","SG9999015952.SGD","LU2087621335.USD","LU1057294990.SGD","LU0965509010.AUD","IE00B19Z3B42.SGD","LU1585245621.USD","LU2324357040.USD","GILD","LU0058720904.USD","LU0965509283.SGD","LU1037948541.HKD","IE00B19Z3581.USD","LU0965508806.USD","LU1778281490.HKD","LU1023059063.AUD","LU0320765992.SGD","LU1066053197.SGD","LU0882574055.USD","BK4550","LU1674673428.USD","LU1674673691.USD","BK4588","BK4566","LU2089984988.USD","IE00B7SZLL34.SGD","LU0289739699.SGD","LU0109394709.USD","IE0002270589.USD","LU0889565916.HKD","SG9999015986.USD","IE00BSNM7G36.USD","BK4578","IE00BKVL7J92.USD","LU2112291526.USD","SG9999015945.SGD","LU1430594728.SGD","BK4583","LU1066051498.USD","SG9999015978.USD","LU1839511570.USD","LU0114720955.EUR","LU1571399168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120460171","title":"吉利德基金會斥資1200萬美元賦能社區衞生工作者，在14個州及哥倫比亞特區擴大艾滋病預防計劃","url":"https://stock-news.laohu8.com/highlight/detail?id=1120460171","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120460171?lang=zh_tw&edition=fundamental","pubTime":"2026-03-02 21:31","pubTimestamp":1772458277,"startTime":"0","endTime":"0","summary":"吉利德基金会近日宣布投入1200万美元资金，旨在强化社区卫生工作者的能力建设，并在全美14个州及哥伦比亚特区大幅拓展艾滋病预防项目。这项重大投资将重点支持基层医疗网络，通过专业培训提升社区健康服务人员的技能水平，同时扩大艾滋病检测、宣传教育及早期干预措施的覆盖范围。\n资金将用于创新预防模式的推广，包括扩大暴露前预防药物的可及性，并针对高危人群开展精准防控。该项目预计将惠及数十万弱势群体，特别是在医疗资源匮乏地区构建更完善的艾滋病防治体系。此次行动展现了基金会通过社区赋能应对公共卫生挑战的战略眼光，有望为全美艾滋病防控网络注入新动能。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","GILD","IE00B19Z3581.USD","LU0965508806.USD","BK4588","IE00B19Z3B42.SGD","IE00B3T34201.USD","IE00BZ1G4Q59.USD","LU0289739699.SGD","LU1066051498.USD","LU1066053197.SGD","LU0109394709.USD","LU1674673691.USD","BK4568","LU2087621335.USD","BK4585","LU2089984988.USD","LU0965509101.SGD","LU1571399168.USD","LU1057294990.SGD","SG9999015945.SGD","LU1674673428.USD","BK4139","LU0058720904.USD","LU0861579265.USD","IE00B7SZLL34.SGD","LU0823416689.USD","SG9999015986.USD","LU1778281490.HKD","LU1037948541.HKD","LU0114720955.EUR","LU0122379950.USD","SG9999015952.SGD","LU1037948897.HKD","LU1430594728.SGD","LU0320765992.SGD","LU1839511570.USD","BK4566","LU0965509283.SGD","BK4578","BK4532","LU1023059063.AUD","LU1061106388.HKD","LU1585245621.USD","BK4583","LU2112291526.USD","IE0002270589.USD","LU0965509010.AUD","IE00BKVL7J92.USD","LU2324357040.USD","SG9999015978.USD","LU0234570918.USD","LU0882574055.USD","LU2468319806.SGD","IE00BSNM7G36.USD","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616937339","title":"在晚期研究中，United Therapeutics 的藥物減緩了罕見肺病的惡化速度","url":"https://stock-news.laohu8.com/highlight/detail?id=2616937339","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616937339?lang=zh_tw&edition=fundamental","pubTime":"2026-03-02 19:54","pubTimestamp":1772452443,"startTime":"0","endTime":"0","summary":"更新版 3-在晚期研究中，United Therapeutics 的药物减缓了罕见肺病的恶化速度在第 5 段中添加高管评论，在第 8 段中添加分析师评论Padmanabhan Ananthan路透3月2日 - United Therapeutics UTHR.O周一称，在一项晚期研究中，该公司用于治疗一种罕见肺病的实验性药物将疾病恶化的风险降低了55%。United Therapeutics公司已经在销售其他获得FDA批准的PAH治疗药物，包括每天三次的口服药物Orenitram、连续输液疗法Remodulin以及吸入式Tyvaso和Tyvaso DPI。他预计 ralinepag 将获得 FDA 的批准，并认为 PAH 一线患者对它的接受度很高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nL4S3ZQ115:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JNJ","LU0912757837.SGD","LU1066051498.USD","LU1066053197.SGD","LU0345769631.USD","LU1059921491.USD","LU0795875169.SGD","LU2361044949.HKD","LU1116320901.HKD","LU1057294990.SGD","LU1894683264.USD","IE0034235303.USD","LU1989771016.USD","LU2430703251.USD","LU1267930813.SGD","LU0070302665.USD","BK4592","LU1037948541.HKD","IE00BGHQF631.EUR","LU2471134952.CNY","SGXZ57979304.SGD","IE00B1BXHZ80.USD","SG9999014575.USD","MRK","LU1732800096.USD","IE00BDGV0183.EUR","LU1989772923.USD","LU0265550359.USD","LU1674673428.USD","LU2430703178.SGD","GILD","LU1989772840.SGD","IE00B3T34201.USD","LU2471134879.HKD","LU1023059063.AUD","LU0861579265.USD","LU2461242641.AUD","LU1196500208.SGD","LU1917777945.USD","UTHR","LU1162221912.USD","LU0208291251.USD","LU1974910355.USD","LU0320765489.SGD","BK4550","LU0889565916.HKD","LU0965509101.SGD","LU1571399168.USD","SG9999015945.SGD","IE0002270589.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614869355","title":"吉利德科學股票2月27日盤中上漲3.72%：真相來了","url":"https://stock-news.laohu8.com/highlight/detail?id=2614869355","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614869355?lang=zh_tw&edition=fundamental","pubTime":"2026-02-28 02:16","pubTimestamp":1772216170,"startTime":"0","endTime":"0","summary":"• 吉利德科学将以78亿美元收购Arcellx, Inc.。\n• 吉利德报告第四季度产品销售额增长5%至79亿美元。\n• FDA批准扩大吉利德Yescarta淋巴瘤疗法的适用范围。","market":"nz","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/stocks/261630471-market-movers-gild-20260227","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0122379950.USD","BK4532","SG9999015986.USD","IE00BSNM7G36.USD","LU0058720904.USD","LU1571399168.USD","LU2468319806.SGD","LU1066053197.SGD","LU1839511570.USD","SG9999015952.SGD","BK4139","IE00B19Z3B42.SGD","LU1023059063.AUD","LU1778281490.HKD","BK4568","IE00B7SZLL34.SGD","LU0114720955.EUR","BK4583","IE00B19Z3581.USD","LU0965509010.AUD","BK4550","LU0109394709.USD","LU0965508806.USD","LU1585245621.USD","LU1674673428.USD","LU0861579265.USD","LU1037948541.HKD","LU0889565916.HKD","LU0965509283.SGD","LU2324357040.USD","LU0823416689.USD","LU0320765992.SGD","GILD","LU0234570918.USD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LU0882574055.USD","LU2087621335.USD","LU2089984988.USD","LU1430594728.SGD","LU2112291526.USD","SG9999015945.SGD","LU1057294990.SGD","LU1061106388.HKD","IE00B3T34201.USD","LU1066051498.USD","LU0965509101.SGD","SG9999015978.USD","LU0289739699.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614058156","title":"吉利德公司的試驗性艾滋病治療藥物在研究中顯示出較低的停藥率","url":"https://stock-news.laohu8.com/highlight/detail?id=2614058156","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614058156?lang=zh_tw&edition=fundamental","pubTime":"2026-02-26 03:24","pubTimestamp":1772047466,"startTime":"0","endTime":"0","summary":"吉利德公司的试验性艾滋病治疗药物在研究中显示出较低的停药率路透2月25日 - 吉利德科学公司周三表示，其试验性单片艾滋病病毒治疗药物的耐受性普遍良好，停药率低，这使单片疗法成为患者在病毒已被抑制后转用的一种潜在选择。本周三，吉利德公司在丹佛举行的一次会议上公布了另一项晚期试验的详细结果 ，吉利德公司正在准备向监管部门提交这种试验性复方制剂的申请。吉利德公司表示，它计划向监管机构提交这两项试验的数据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nL4S3ZL1Z0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1674673691.USD","LU1023059063.AUD","IE00BSNM7G36.USD","LU0823416689.USD","BK4550","LU1571399168.USD","LU1430594728.SGD","BK4566","LU0861579265.USD","LU0965509010.AUD","LU1061106388.HKD","SG9999015978.USD","LU0122379950.USD","LU2112291526.USD","IE00B19Z3581.USD","LU1037948541.HKD","BK4532","LU1066053197.SGD","LU1585245621.USD","LU0320765992.SGD","LU1066051498.USD","BK4585","BK4578","GILD","IE00B19Z3B42.SGD","LU1778281490.HKD","LU1037948897.HKD","LU2089984988.USD","BK4139","BK4568","LU0058720904.USD","LU0114720955.EUR","IE00B3T34201.USD","IE00BKVL7J92.USD","LU0965509283.SGD","LU0234570918.USD","LU1057294990.SGD","LU2324357040.USD","SG9999015952.SGD","IE00B7SZLL34.SGD","SG9999015945.SGD","LU1674673428.USD","BK4588","BK4583","LU0889565916.HKD","LU1839511570.USD","LU0882574055.USD","LU2087621335.USD","IE0002270589.USD","SG9999015986.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613748308","title":"BUZZ-券商觀點：吉利德收購 Arcellx 是對癌症細胞療法的長期押注","url":"https://stock-news.laohu8.com/highlight/detail?id=2613748308","media":"路透中文","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613748308?lang=zh_tw&edition=fundamental","pubTime":"2026-02-24 22:57","pubTimestamp":1771945053,"startTime":"0","endTime":"0","summary":"2月24日 - ** 吉利德科学公司GILD.O同意支付高达78亿美元  收购合作伙伴Arcellx公司，这是该公司自2020年以来最大的一笔交易，因为该公司希望通过一种前景看好的细胞疗法候选药物anito-cel来加强其癌症治疗产品阵容。** Morningstar 称，该公司目前预测到第 10 年，anito-cel 的年销售额将达到 40 亿美元，但又补充说，竞争可能会限制其向早期应用的扩展。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nL4T3ZK1H1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","LU0823416689.USD","LU2112291526.USD","LU0965509101.SGD","LU2468319806.SGD","LU1066051498.USD","LU0122379950.USD","LU1778281490.HKD","IE00B19Z3581.USD","BK4585","IE0002270589.USD","ACLX","LU2087621335.USD","LU1066053197.SGD","SG9999015952.SGD","LU0289739699.SGD","LU1023059063.AUD","IE00BKVL7J92.USD","BK4566","LU0320765992.SGD","LU2324357040.USD","LU0058720904.USD","SG9999015945.SGD","LU1839511570.USD","LU1057294990.SGD","IE00BSNM7G36.USD","IE00B7SZLL34.SGD","LU0109394709.USD","BK4139","SG9999015986.USD","LU0234570918.USD","LU1674673691.USD","BK4578","LU0965509283.SGD","IE00BZ1G4Q59.USD","LU1061106388.HKD","LU1430594728.SGD","BK4588","BK4532","IE00B19Z3B42.SGD","LU0861579265.USD","LU1585245621.USD","LU2089984988.USD","BK4568","GILD","LU1037948897.HKD","LU1674673428.USD","IE00B3T34201.USD","LU1571399168.USD","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613764020","title":"78億美金，跨國藥企達成閃電併購","url":"https://stock-news.laohu8.com/highlight/detail?id=2613764020","media":"药圈观察局","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613764020?lang=zh_tw&edition=fundamental","pubTime":"2026-02-23 20:03","pubTimestamp":1771848202,"startTime":"0","endTime":"0","summary":"2023年6月，因一名患者死亡，FDA暂停了anito-cel的关键II期临床试验。然而，仅两个月后，FDA经审查解除了搁置，试验重回正轨。同年11月，Kite进一步扩大合作，支付2.85亿美元以获得Arcellx另一条管线ACLX-001的权益，并将对Arcellx的股权投资增至2亿美元，持股比例达到约13%。其市值在不到三年内从不足4亿美元飙升至收购前的数十亿美元，堪称“十倍股”。据悉，此次收购的灵魂是Arcellx的两大核心资产。市场方面，多发性骨髓瘤CAR-T市场预计在2030年达到120亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602232009079541ac53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602232009079541ac53&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BSNM7G36.USD","CVR","LU0234570918.USD","LU1037948897.HKD","GILD","SG9999015952.SGD","LU0122379950.USD","BK4585","LU2087621335.USD","BK4566","LU0965509010.AUD","LU0289739699.SGD","LU0109394709.USD","LU0861579265.USD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","LU1061106388.HKD","LU1066051498.USD","LU1778281490.HKD","LU0965508806.USD","BK4568","LU0320765992.SGD","LU2468319806.SGD","LU0965509283.SGD","SG9999015945.SGD","IE00BKVL7J92.USD","LU1066053197.SGD","BK4550","LU0889565916.HKD","LU0058720904.USD","LU0823416689.USD","BK4583","LU1571399168.USD","LU1674673691.USD","LU1057294990.SGD","LU2089984988.USD","BK4588","BK4578","LU0882574055.USD","LU1037948541.HKD","ORR","LU1674673428.USD","IE00B3T34201.USD","IE00B7SZLL34.SGD","IE0002270589.USD","LU0114720955.EUR","IE00BZ1G4Q59.USD","LU2324357040.USD","SG9999015986.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177273649","title":"特定條件下交易終止  Arcellx將向吉利德科學支付2.6億美元解約金","url":"https://stock-news.laohu8.com/highlight/detail?id=1177273649","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177273649?lang=zh_tw&edition=fundamental","pubTime":"2026-02-23 19:51","pubTimestamp":1771847474,"startTime":"0","endTime":"0","summary":"根据协议条款约定，若本次合作因特定情形提前终止，生物技术公司Arcellx须向吉利德科学支付高达2.6亿美元的终止费用。该条款作为交易保护机制，旨在保障吉利德科学的权益，同时反映出双方对合作价值的共同认可。\n交易文件明确规定，解约金的触发条件与终止情形直接关联，具体条款细节未完全公开。这一安排既体现了交易双方对合作稳定性的重视，也为可能出现的意外情况提供了明确的解决方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","LU1674673691.USD","LU2087621335.USD","LU1674673428.USD","LU0234570918.USD","IE00BKVL7J92.USD","LU1571399168.USD","LU0965508806.USD","LU1839511570.USD","SG9999015986.USD","LU1057294990.SGD","BK4568","BK4532","LU0114720955.EUR","BK4588","LU0889565916.HKD","LU0861579265.USD","LU0965509101.SGD","SG9999015945.SGD","LU0109394709.USD","IE00B19Z3581.USD","GILD","IE00B3T34201.USD","LU1066051498.USD","LU0965509010.AUD","IE00B19Z3B42.SGD","LU0823416689.USD","IE00B7SZLL34.SGD","IE00BZ1G4Q59.USD","LU2112291526.USD","LU2324357040.USD","BK4550","LU0122379950.USD","LU1778281490.HKD","SG9999015978.USD","LU1061106388.HKD","LU1023059063.AUD","LU1066053197.SGD","LU2468319806.SGD","IE0002270589.USD","LU0058720904.USD","BK4578","LU0320765992.SGD","LU1430594728.SGD","BK4139","SG9999015952.SGD","LU0289739699.SGD","BK4583","LU0882574055.USD","LU2089984988.USD","LU0965509283.SGD","IE00BSNM7G36.USD","BK4585","LU1037948541.HKD","LU1037948897.HKD","LU1585245621.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":2,"totalSize":160,"code":"91000000","status":"200"}]}}